Clinical Trial Update: A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating daily rifapentine with isoniazid (1HP) for tuberculosis prevention in children under 13, including those with and without …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• ISONIAZID (ISONIAZID)
• rifapentine (rifapentine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Tuberculosis | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING